Prevalence and Features Associated With Restless Leg Syndrome in Postmenopausal Females
dc.authorid | Kablan, Yüksel/0000-0002-5581-2968 | |
dc.authorwosid | Kablan, Yüksel/AAB-5049-2021 | |
dc.contributor.author | Unaldi Karaer, Hatice | |
dc.contributor.author | Kaplan, Yuksel | |
dc.contributor.author | Kurt, Semiha | |
dc.contributor.author | Demirturk, Fazli | |
dc.date.accessioned | 2024-08-04T20:39:51Z | |
dc.date.available | 2024-08-04T20:39:51Z | |
dc.date.issued | 2014 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Background: Animal and human studies have shown that estrogen modulates dopaminergic activity. The hypoestrogenic state associated with menopause, characterized by a decreased ovarian follicular response to gonadotropins and estrogen, affects the nervous system at multiple anatomical or functional sites. Aims: We investigated the prevalence of restless leg syndrome (RLS) in postmenopausal females and assessed the relationship between RLS and the clinical features of menopause. Methods: We enrolled 523 menopausal females in the study. Of those, 334 (63.86%) did not meet the inclusion criteria and were excluded. Of the remaining 189 postmenopausal patients, 73 met all of the diagnostic criteria for RLS; however, 47 of those had at least one factor related to secondary RLS and were excluded from the study. The remaining 26 (18.3%) postmenopausal patients with idiopathic RLS were categorized as group 1. The control group included 56 postmenopausal females free of RLS and matched by age (+2 years) to group 1. Results: Onset age of menopause was earlier and surgical menopause was more frequent in group 1. The Pearson's correlation test revealed a strong and significant correlation between the onset ages of menopause and RLS. Conclusions: Estrogen receptors are widely distributed throughout the central and peripheral nervous systems. Estrogen modulates dopaminergic activity in the nigrostriatal system. Menopause is characterized by hypoestrogenemia, and may be a risk factor for the development or worsening of RLS symptoms. | en_US |
dc.identifier.endpage | 585 | en_US |
dc.identifier.issn | 1302-1664 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.scopus | 2-s2.0-84907272065 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 578 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/96557 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000347120800014 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Journal Neurological Sciences | en_US |
dc.relation.ispartof | Journal of Neurological Sciences-Turkish | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Menopause | en_US |
dc.subject | Restless Legs Syndrome | en_US |
dc.subject | Estrogen | en_US |
dc.subject | Hypoestrogenemia | en_US |
dc.title | Prevalence and Features Associated With Restless Leg Syndrome in Postmenopausal Females | en_US |
dc.type | Article | en_US |